BVF PARTNERS L P/IL Insider Trading $CCXI ChemoCentryx, Inc.
Get free email notifications about insider trading for BVF PARTNERS L P/IL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of BVF PARTNERS L P/IL. BVF PARTNERS L P/IL is in Capstone Therapeutics Corp. ($CAPS) and 10% Owner in CTI BIOPHARMA CORP ($CTIC) and Director in CTI BIOPHARMA CORP ($CTIC) and 10% Owner in XOMA Corp ($XOMA) and Director in XOMA Corp ($XOMA) and 10% Owner in ARQULE INC ($ARQL) and 10% Owner in INFINITY PHARMACEUTICALS, INC. ($INFI) and in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and 10% Owner in FIVE PRIME THERAPEUTICS, INC. ($FPRX) and in CYTOKINETICS INC ($CYTK) and 10% Owner in CYTOKINETICS INC ($CYTK) and 10% Owner in GLYCOMIMETICS INC ($GLYC) and 10% Owner in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in Syndax Pharmaceuticals Inc ($SNDX) and in Eledon Pharmaceuticals, Inc. ($NVUS) and in ChemoCentryx, Inc. ($CCXI) and 10% Owner in ChemoCentryx, Inc. ($CCXI) and 10% Owner in IMMUNE DESIGN CORP. ($IMDZ) and 10% Owner in Calithera Biosciences, Inc. ($CALA) and 10% Owner in Principia Biopharma Inc. ($PRNB) and 10% Owner in PIERIS PHARMACEUTICALS, INC. ($PIRS) and 10% Owner in Xenon Pharmaceuticals Inc. ($XENE) and 10% Owner in Nivalis Therapeutics, Inc. ($NVLS) and 10% Owner in Merus N.V. ($MRUS) and in IDEAYA Biosciences, Inc. ($IDYA) and 10% Owner in IDEAYA Biosciences, Inc. ($IDYA) and Director in Rain Therapeutics Inc. ($RAIN) and Director in Olema Pharmaceuticals, Inc. ($OLMA) and Director in Kymera Therapeutics, Inc. ($KYMR).
BVF PARTNERS L P/IL in ChemoCentryx, Inc.
Trading Symbol: CCXIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of BVF PARTNERS L P/IL:
Holdings: 0 shares
Current Value: $0
Latest Transaction: Nov 05 2015
$CCXI Market Capitalization: $309.30M
$CCXI Previous Close: $6.67
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of BVF PARTNERS L P/IL in ChemoCentryx, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALPN, ARQL, CALA, CAPS, CCXI, CNCE, CTIC, CYTK, ELDN, FPRX, GLYC, IDYA, IMDZ, INFI, KYMR, MRUS, OLMA, PIRS, PRNB, RAIN, SNDX, XENE, XOMA
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Nov 05 2015 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | Sell | J | 0.00 | 2,384,577 | 0 | 0 | 2.4 M to 0 (-100.00 %) | |
Nov 05 2015 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | Sell | S | 7.00 | 287,000 | 2,009,057 | 2,384,577 | 2.7 M to 2.4 M (-10.74 %) | |
Nov 05 2015 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | Sell | S | 6.98 | 73,000 | 509,343 | 2,671,577 | 2.7 M to 2.7 M (-2.66 %) | |
Nov 02 2015 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 6.97 | 50,000 | 348,515 | 2,744,577 | 2.8 M to 2.7 M (-1.79 %) |
Jun 11 2015 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 9.01 | 31,000 | 279,229 | 2,794,577 | 2.8 M to 2.8 M (-1.10 %) |
Jun 11 2015 | CCXI | ChemoCentryx, Inc. | BVF PARTNERS L P/IL | 10% Owner | Sell | S | 9.00 | 924,700 | 8,322,392 | 2,825,577 | 3.8 M to 2.8 M (-24.66 %) |
Page: 1